MYC and diffuse large B-cell lymphoma: Transcriptome analysis has shown that the MYC signature is the hallmark signaling difference between Burkitt's lymphomas and diffuse large B-cell lymphomas with: upregulation of MYC-target genes and downregulation of genes involved in the NF-kB and interferon responses [23], [24], [27].